RESTORE PLC
Company number 05169780 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: B (Incomplete Chart - Stable Condition)
I am assigning a provisional grade of B because, while the patient appears robust based on its structural and compliance vitals, the clinical file is missing the most critical lab results. Restore PLC is a mature, active Public Limited Company with a strong heartbeat—evidenced by its longevity and substantial share capital. However, without the quantitative financial metrics (profit, revenue, liquidity ratios), a complete cardiovascular assessment is impossible. The structural health is excellent, but the metabolic financial health requires deeper lab work.
2. Key Vital Signs
- Pulse & Heart Rate (Compliance & Filing Status): Strong and Steady. The company’s accounts are up to date, and the next confirmation statement is not due until mid-2027, with no overdue filings. This indicates a healthy, disciplined corporate routine with no arrhythmias or signs of administrative distress.
- Blood Pressure (Capitalization): Healthy Baseline. The share capital stands at just over £6.19 million. For a PLC, this indicates a solid foundation of equity, suggesting the business is not operating on empty and has the baseline stamina required of a public company.
- Immune System (Corporate Governance): Robust. The boardroom is well-staffed with multiple directors and a dedicated company secretary. There are no records of disqualification orders against any directors, meaning the leadership team has a clean bill of health and is legally fit to direct.
- Medical History (Corporate Evolution): Resilient. Incorporated in 2004, the company has evolved through at least two major rebrandings (from Dyno Group PLC to Mavinwood PLC, and finally to Restore PLC in 2010). This shows an ability to adapt and survive changing market conditions over a 20-year history.
- Vital Organs (Business Operations): Functional. Operating in business support services (specifically data management and document lifecycle services), the company is engaged in a sector with modern relevance. Data management is the lifeblood of modern commerce, positioning the company well for ongoing relevance.
3. Diagnosis
Based on the observable symptoms, Restore PLC is in a state of structural and administrative wellness. The transition to a Public Limited Company and the maintenance of group accounts suggest a substantial, growing organization that has matured past the startup phase. The recent resignation of Director Susan Jane Davy (May 2026) appears to be an isolated symptom rather than a systemic issue, as the rest of the board remains intact.
However, a major caveat in this diagnosis is the absence of financial blood work. Because the company falls under the "Group" and "Large" categories, it is subject to full filing requirements, yet the specific turnover, net assets, and P&L reserve figures are not present in this current chart. A PLC of this size should have rich, audited financial data available. Without assessing working capital, debt levels, and profit margins, we cannot rule out underlying conditions such as over-leverage (high blood pressure) or cash flow anemia. Furthermore, as a PLC, the "Persons with Significant Control" register correctly shows a statement rather than specific individuals, as ownership is distributed among shareholders—this is a normal anatomical feature for a public company.
4. Recommendations
To ensure continued financial wellness and achieve an 'A' grade, the following preventative and proactive measures are recommended:
- Complete the Blood Work (Obtain Audited Accounts): Immediately pull the latest full audited group accounts from Companies House. We must examine the balance sheet for liquidity ratios and the P&L for margin health to ensure the company isn't structurally sound but financially anemic.
- Monitor the Boardroom for Infection: Keep a close eye on the recent board change. While one resignation is normal, ensure there is a smooth transition of responsibilities to prevent any temporary loss of corporate governance or strategic focus.
- Leverage the Sector's Health: As a provider of secure, sustainable business lifecycle services, the company should continue to invest in digital transformation and data security. The sector is highly competitive, and maintaining a strong immune system against technological obsolescence is critical.
- Maintain Compliance Hygiene: Continue the excellent track record of timely filings. Late filings can cause fevers in the form of penalties and loss of market confidence, which is particularly dangerous for a public company.